[go: up one dir, main page]

WO2004073610A3 - Estrogen receptor modulators - Google Patents

Estrogen receptor modulators Download PDF

Info

Publication number
WO2004073610A3
WO2004073610A3 PCT/US2004/003678 US2004003678W WO2004073610A3 WO 2004073610 A3 WO2004073610 A3 WO 2004073610A3 US 2004003678 W US2004003678 W US 2004003678W WO 2004073610 A3 WO2004073610 A3 WO 2004073610A3
Authority
WO
WIPO (PCT)
Prior art keywords
disease
estrogen
compounds
receptor modulators
estrogen receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/003678
Other languages
French (fr)
Other versions
WO2004073610A2 (en
Inventor
Wanying Sun
Lovji D Cama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of WO2004073610A2 publication Critical patent/WO2004073610A2/en
Publication of WO2004073610A3 publication Critical patent/WO2004073610A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, metastatic bone disease, Paget s disease, periodontal disease, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restenosis, gynecomastia, vascular smooth muscle cell proliferation, obesity, incontinence, and cancer.
PCT/US2004/003678 2003-02-13 2004-02-09 Estrogen receptor modulators Ceased WO2004073610A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44716303P 2003-02-13 2003-02-13
US60/447,163 2003-02-13

Publications (2)

Publication Number Publication Date
WO2004073610A2 WO2004073610A2 (en) 2004-09-02
WO2004073610A3 true WO2004073610A3 (en) 2004-11-25

Family

ID=32908412

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/003678 Ceased WO2004073610A2 (en) 2003-02-13 2004-02-09 Estrogen receptor modulators

Country Status (1)

Country Link
WO (1) WO2004073610A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354927B2 (en) 2004-09-07 2008-04-08 Wyeth 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
JP4992091B2 (en) * 2005-02-17 2012-08-08 ハダシット メディカル リサーチ サービシーズ アンド デベロップメント リミテッド Bisphosphonates for treating endometriosis
NL2000351C2 (en) 2005-12-22 2007-09-11 Pfizer Prod Inc Estrogen modulators.
CN102675326B (en) * 2012-04-26 2014-08-20 华东理工大学 Preparation method of 3,4-dihydrobenzene benzopyran [3,4-c] pyrazole tricyclic compound
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
CN104592202A (en) * 2015-01-23 2015-05-06 武汉工程大学 3-ethyl-N-methyl-[(N-methyl-N-[(2-pyridyl)carbamoyl)phenyl]-pyrazole-5-carboxamide as well as preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624102A (en) * 1969-05-21 1971-11-30 Warner Lambert Co Substituted benzopyranopyrazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624102A (en) * 1969-05-21 1971-11-30 Warner Lambert Co Substituted benzopyranopyrazoles

Also Published As

Publication number Publication date
WO2004073610A2 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
SI1501819T1 (en) Estrogen receptor modulators
WO2004073612A3 (en) Estrogen receptor modulators
HK1048592A1 (en) Estrogen receptor modulators
WO2002091993A3 (en) Estrogen receptor modulators
WO2006062876A3 (en) Estrogen receptor modulators
NO20072771L (en) estrogen
WO2002041835A3 (en) Estrogen receptor modulators
WO2002032377A3 (en) Estrogen receptor modulators
WO2004091488A3 (en) Estrogen receptor modulators
WO2007062230A3 (en) Nuclear receptor binding agents
AU2002245317A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
WO2008091555A3 (en) Nuclear receptor binding agents
WO2002032373A3 (en) Estrogen receptor modulators
WO2004073610A3 (en) Estrogen receptor modulators
WO2006081152A3 (en) Estrogen receptor modulators
WO2005097141A3 (en) Estrogen receptor modulators
WO2002053522A3 (en) Novel estrogen receptor ligands and methods i
WO2007089291A3 (en) Estrogen receptor modulators
WO2001077057A3 (en) Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
WO2002058639A3 (en) Pyranoflavonoid compounds and their use as estrogen receptor modulators
WO2004026887A3 (en) Estrogen receptor modulators
WO2008057309A3 (en) Estrogen receptor modulators
WO2009059806A3 (en) Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine
WO2000076552A8 (en) Methods and compositions for control of bone formation via modulation of leptin activity
DOP2005000224A (en) MODULATORS OF STROGEN RECEIVERS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase